Meng Fanqi, Zou Le, Zhang Tengyu, Jiang Lei, Ding Yao, Yu Peng, Peng Jie
Department of Drug Analysis, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan Province, China,
Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
Cancer Manag Res. 2018 Aug 23;10:2859-2870. doi: 10.2147/CMAR.S164766. eCollection 2018.
The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which directly leads to chemotherapy failure. However, most of the currently used detection methods in MDR-related studies are qualitative or semiquantitative, but not quantitative. As a result, the measurement criteria of different experiments are not unified. Moreover, there are many contradictory results of the studies of the induction effect of drugs on ABC transporters. So, it is necessary to establish a quantitative assay for the quantification of P-gp, MRP1, and BCRP to study the mechanism of drug resistance.
In this paper, a novel and advanced liquid chromatography/mass spectrometry (MS)/MS-based targeted proteomics method for the quantification of P-gp, MRP1, and BCRP was developed and validated. Then, the cell lines MCF-7, HepG-2, and SMMC-7721 were, respectively, induced by different concentrations of doxorubicin (adriamycin [ADM]), mitoxantrone (MX), and methotrexate (MTX), to establish resistance cell lines. The method established was used to quantify the expression of P-gp, MRP1, and BCRP.
The result showed that the induction effects of drugs on protein were relatively stable and selective. ADM, MX, and MTX could induce overexpression of P-gp, MRP1, and BCRP. And, the induction effect of different drugs on proteins was selective. The pattern of overexpression of ABC transporters in the three types of resistance cell lines was different.
During the development of drug resistance, the cell type and patch, but not drug type, were the most important determinant factors of the overexpression level of ABC transporters in resistance cell lines. This study provides a good foundation for understanding the development of drug resistance in cell lines and can be used to explain the contradictory results in other published studies as described above.
ATP结合盒转运蛋白(ABC转运蛋白)的过表达,主要包括通透性糖蛋白(P - gp)、多药耐药相关蛋白1(MRP1)和乳腺癌耐药蛋白(BCRP),是导致多药耐药(MDR)发生的主要原因之一,直接导致化疗失败。然而,目前在MDR相关研究中使用的大多数检测方法都是定性或半定量的,而非定量的。因此,不同实验的测量标准不统一。此外,关于药物对ABC转运蛋白诱导作用的研究结果存在许多矛盾之处。所以,有必要建立一种定量测定P - gp、MRP1和BCRP的方法来研究耐药机制。
本文开发并验证了一种基于液相色谱/质谱(MS)/MS的新型先进靶向蛋白质组学法,用于定量测定P - gp、MRP1和BCRP。然后,分别用不同浓度的阿霉素(多柔比星[ADM])、米托蒽醌(MX)和甲氨蝶呤(MTX)诱导MCF - 7、HepG - 2和SMMC - 7721细胞系,建立耐药细胞系。所建立的方法用于定量测定P - gp、MRP1和BCRP的表达。
结果表明,药物对蛋白质的诱导作用相对稳定且具有选择性。ADM、MX和MTX可诱导P - gp、MRP1和BCRP过表达。并且,不同药物对蛋白质的诱导作用具有选择性。三种耐药细胞系中ABC转运蛋白的过表达模式不同。
在耐药发生过程中,细胞类型和批次,而非药物类型,是耐药细胞系中ABC转运蛋白过表达水平的最重要决定因素。本研究为理解细胞系中耐药的发生提供了良好基础,可用于解释上述其他已发表研究中的矛盾结果。